The fact that hippocampal neurons are capable of producing estrogens raises the question of the functional significance of this endogenous steroid. As an internal control we studied the expression of ERα and β. In dispersion cultures, ERα was upregulated, whereas ERβ expression was decreased in response to estradiol. Vice versa, ERα was downregulated and ERβ upregulated in response to letrozole. Since ERs are ligand-inducible transcription factors, these data show that the cultures are responsive to estrogen-treatment (Prange-Kiel et al.
2003).
Synaptic proteins
To further substantiate the role of endogenous estrogens on synaptic plasticity, we studied the effect of endogenous estrogen on synaptic proteins (Kretz et al.
2004) such as synaptophysin. This protein is a component of the transmitter vesicle membrane, and is commonly used as a presynaptic marker (for review see: Sudhof and Jahn
1991). As an example of a postsynaptic marker we studied spinophilin, a cytoskeleton associated protein, which has been shown to be enriched in spines (Allen et al.
1997; Feng et al.
2000). In hippocampal slice cultures and dispersion cultures, immunoreactivity of both proteins was found in somata and dendrites, but was also present as punctate staining, indicating the labeling of spines (spinophilin) or presynaptic boutons (synaptophysin). When we treated the cultures with letrozole, we found a clear-cut downregulation of both proteins; this could be verified by subsequent image analysis of the immunolabeling. The letrozole-induced downregulation was rescued by simultaneous application of estradiol to the cultures (Rune et al.
2002; Rune et al.
2006). The findings on synaptophysin confirm observations by other groups under in vivo (Yankova et al.
2001; Choi et al.
2003) and in vitro (Yokomaku et al.
2003) conditions.
In siRNA against StAR transfected cells, thus in cells in which estrogen synthesis was blocked from its beginning, the expression of spinophilin as well as of synaptophysin was significantly downregulated. A rescue of the knock-down in these transfected cultures was achieved by administration of estradiol to the cultures, but not by application of cholesterol. This finding strongly indicates that cholesterol is ineffective regarding synapse formation when the access of cholesterol to the first steroidogenic enzyme in the inner mitochondrial membrane is blocked. A slight increase in synaptic protein expression was found after cholesterol treatment. This slight increase was expected, since non-transfected cells in the culture dish, which continue to synthesize estradiol, are stimulated by cholesterol.
Supplementation of the medium with cholesterol, testosterone, or estradiol resulted in clear-cut upregulation of synaptic proteins. Notably, in dispersed cultures, where cholesterol synthesis, testosterone synthesis, and estradiol synthesis were simultaneously inhibited, a rescue of synaptic protein expression was achieved solely by estradiol, but neither by cholesterol nor by testosterone, pointing to the high specificity of aromatase activity in steroid-regulated synaptic plasticity in the hippocampus. The simultaneous inhibition of cholesterol synthesis, testosterone synthesis, and estradiol synthesis resulted in a decrease in the expression of synaptic proteins. Remarkably, neither treatment with cholesterol nor with testosterone abolished the negative effect of this combined inhibition. The rescue of synaptic protein expression was solely achieved by treatment with estradiol. This finding points to the high specificity of aromatase activity in steroid-regulated synaptic plasticity in the hippocampus.
Hippocampal spine synapses
As a next step, we investigated the effect of endogenous estradiol on spine and spine synapse formation (Kretz et al.
2004). By inhibiting aromatase activity with letrozole, we lowered the endogenous estradiol levels in hippocampal slice cultures. In electron micrographs we analyzed the number of spine synapses, shaft synapses, and the number of boutons by using unbiased stereological methods. Inhibition of estrogen synthesis resulted in a significant downregulation of spine synapses and of presynaptic boutons. The results of this analysis were confirmed by spine counts in Lucifer yellow-filled neurons in dispersion cultures (Kretz et al.
2004). The effects of letrozole on synaptogenesis were rescued by simultaneous application of 17β-estradiol to the cultures (Zhou et al.
2007).
In agreement with previous findings, stereological determination of spine synapse number in organotypic slice cultures revealed that the number of spine synapses increased significantly in response to cholesterol (Mauch et al.
2001). Testosterone treatment, performed for control purposes, also resulted in an increase in spine synapse number. Most strikingly, when we supplemented the medium with cholesterol together with letrozole, cholesterol-induced synapse formation was abolished, strongly suggesting that cholesterol does not induce synapse formation directly but serves as a substrate for estrogen synthesis. Similarly, after blockade of ERs using ICI 182 780, no increase in spine synapse number was found in response to cholesterol in hippocampal slice cultures. A rescue of spine synapse number after letrozole treatment was not achieved with testosterone either.
In order to test the effect of exogenous estradiol we also treated slice cultures and dispersion cultures with estradiol at a dose of 10
−7 M (Kretz et al.
2004), which induced a significant increase in ERα immunostaining in slice cultures (Rune et al.
2002).
A change in spine synapse number was not found, which raises the question as to why cholesterol increases the number of spine synapses while estradiol does not?
Although application of estradiol to the cultures did not induce spine synapse formation, the pre and postsynaptic markers synaptophysin and spinophilin were upregulated in response to estradiol (Fester et al.
2009). In view of these data the reliability of synaptophysin immunoreactivity and spinophilin immunoreactivity as indicative of the presence of spine synapses, which is taken for granted in many studies (Spencer et al.
2008), appears questionable. An increase in transmitter vesicles in preexisting boutons could provide an alternative explanation for synaptophysin upregulation. Similarly, spinophilin, a protein phosphatase-1 and actin-binding protein localized adjacent to the postsynaptic membrane, plays a role in glutamatergic neurotransmission and dendritic spine morphology. With both proteins the upregulation may serve to increase individual synaptic strength.
To find out why estradiol does not induce spine formation, we further compared the regulation of ERα in response to 17β-estradiol and cholesterol. It has been shown that this ER subtype mediates estrogen-induced spine formation in the CA1 region of the hippocampus (Mukai et al.
2007), and we have shown that ERα is upregulated by 17β-estradiol (Prange-Kiel et al.
2003). In our study, the upregulation of ERα was stronger after treatment of the cultures with cholesterol than after estradiol treatment. This finding suggests that cholesterol-enhanced estrogen synthesis results in higher spine synapse density via upregulation of ERα. Uptake of exogenously applied estradiol from the extracellular space, however, appears to be limited. The degree of ERα upregulation in response to estradiol appears to be insufficient to induce spine synapse formation.
This hypothesis is supported by recent studies, which show that estradiol is actively transported through the plasma membrane (Hammes et al.
2005; Lin and Scanlan
2005). The regulation of this transport is unknown so far. The rescue of the effects after inhibition of estrogen synthesis by estradiol that we found in our study, suggests that this transport may be regulated by intracellular estradiol concentrations. Alternatively, at the plasma membrane high doses of estradiol, such as 10
−7 M estradiol, induce a Ca
2+ influx via membrane-bound non-genomic signaling, which results in a release of Ca
2+ from intracellular stores (Zhao et al.
2005 and our own unpublished observations). Ca
2+ release from intracellular stores, in turn, downregulates aromatase activity via Ca
2+-dependent kinases (Balthazart et al.
2005,
2006) Thus, high doses of estradiol would finally inhibit estradiol synthesis in the neurons. This mechanism of estradiol synthesis inhibition by its product was consistently shown in permanent cell lines (Shimizu et al.
1993).
Long-term potentiation
Very recently, Zhou et al. (unpublished observations) demonstrated that LTP is no longer inducible in hippocampal slice cultures after letrozole treatment. In letrozole-treated cultures, TBS of CA3-CA1 Schaffer collaterals failed to induce LTP. Consistently, immunoreactivity of NR2B NMDA receptors, which mediate estradiol-induced LTP, was downregulated in the stratum radiatum of the CA1 region in the letrozole-treated slice cultures. All effects in response to letrozole were rescued by estradiol. Estradiol increases the magnitude of LTP at CA3-CA1 synapses in the hippocampus. This has been related to the memory-enhancing effects of this hormone (Walf and Frye
2006). Warren et al. (
1995) were the first to demonstrate enhanced synaptic activity in proestrus rats and Cordoba Montoya and Carrer (
1997) found that estrogen facilitates the induction of LTP in the hippocampus of awake rats. Acute application of estradiol to native hippocampal slices in vitro increases NMDA and AMPA receptor (R) transmission and LTP (Foy et al.
1999; Good et al.
1999). In more recent studies, Smith and McMahon (
2005,
2006) demonstrated that the estrogen-induced increase in the magnitude of LTP occurs only when the ratio of NMDA transmission to AMPA transmission is increased (Smith and McMahon
2005). They further showed that blocking NR2B NMDARs prevented the increase in LTP magnitude in response to estradiol (Smith and McMahon
2006). In hippocampal slice cultures, application of 17β-estradiol increased the magnitude of LTP. This effect was, however, not significant.